Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cendres+Métaux operates as a leading Swiss contract manufacturer specializing in high-quality micromechanical components for the dental and medical technology sectors. Its Medtech division develops, manufactures, and sells precision parts for dental restorations and orthopedic implants using biocompatible precious metal alloys and titanium. The company also supplies major global medtech firms with custom components[1][5][7].
No clinical trial results are reported as the business focuses on manufacturing certified medical devices rather than pharmaceuticals or investigational therapies.
The group also has significant operations in luxury watchmaking/jewelry manufacturing and precious metals refining[1][3][4].
It employs around 700 people globally[1][3], with approximately $30.8 million annual revenue attributed to its Medtech division[5].
Subsidiaries include companies focused on specialized machining/coating for both medtech/dental/luxury industries[4].
Shares of the holding company trade OTC in Switzerland but it is not listed on a major stock exchange[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cendres+Métaux.